Agenus Inc.

NASDAQ:AGEN

Biotechnology

Healthcare
$6.14 -0.17%

-$0.01 today

Market cap
$277.81M
Beta
1.54
P/E (TTM)
1.7
EPS (TTM)
$1.70
52W Low $2.71High $7.34

Volume 0.82M

Average 0.82M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$158.31M

FY 2025 · Annual

Investing Cash Flow

$27,000.00

FY 2025 · Annual

+0.0% YoY

Financing Cash Flow

$122.84M

FY 2025 · Annual

+0.0% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(28.72M)(230.66M)(257.44M)(232.27M)(232.27M)
Depreciation & Amortization6.79M6.95M13.59M13.34M13.34M
Deferred Income Tax00000
Stock-Based Compensation19.58M18.34M22.87M17.39M17.39M
Change in Working Capital(9.74M)24.08M10.76M32.6M27.33M
Accounts Receivables(394K)122K(23.46M)25.34M(1.73M)
Inventory00000
Accounts Payables10.82M6.49M21.37M2.01M23.5M
Other Working Capital(20.17M)17.47M12.85M5.25M5.56M
Other Non-Cash Items22.25M5.92M(13.98M)10.62M15.89M
Operating Cash Flow10.15M(175.37M)(224.2M)(158.32M)(158.32M)
Capital Expenditures(33.81M)(53.06M)(9.95M)(576K)(576K)
Acquisitions (Net)0(2.92M)000
Purchases of Investments(14.99M)(24.63M)(20.04M)00
Sales of Investments025M30.03M579K579K
Other Investing Activities5.66M22M3.36M24K24K
Investing Cash Flow(43.15M)(33.61M)3.4M27K27K
Debt Repayment(1.32M)(490K)(8.93M)9.52M2.35M
Common Stock Issued220.65M99.21M133.16M38.82M36.31M
Common Stock Repurchased(1.65M)(3.79M)(5.17M)0(87K)
Dividends Paid00000
Other Financing Activities7.59M898K807K74.5M84.27M
Financing Cash Flow225.26M95.83M119.87M122.84M122.84M
Effect of Forex Changes(164K)(104K)(628K)(260K)(260K)
Net Change in Cash192.1M(113.26M)(101.56M)(35.71M)(35.71M)
Free Cash Flow(23.67M)(228.44M)(234.16M)(158.89M)(158.89M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$232.3M
+ D&A$13.3M
+ Stock-Based Comp$17.4M
+ Deferred Tax$0
+ Working Capital$27.3M
+ Other Non-Cash$15.9M
= Operating Cash Flow-$158.3M
- Capex-$576.0K
= Free Cash Flow-$158.9M

Analysis

FY2025 free cash flow is -$158.9M. FCF conversion is 68.4% of net income. Operating cash flow was -$158.3M, with capex of -$576.0K. The largest bridge item is Working Capital at $27.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 2, 2026
4Statement of changes in beneficial ownershipOct 2, 2026

Does AGEN generate free cash flow?

Agenus Inc. (AGEN) generated -$158.89M of free cash flow in fiscal 2025.

How much operating cash flow does AGEN produce?

Operating cash flow was -$158.31M, before capital expenditures of $576,000.00.